Researchers in Germany have hidden vaccine-grade measles virus inside artificially generated blood cells in order to devise a search-and-destroy therapy for human brain cancer that can?t be “seen” by the immune system.
A research team at Columbia University has designed a novel viral-based gene therapy they say blasts through a body, targeting both primary and distant tumors, while leaving normal cells untouched.
Hepatitis A and hepatitis C, two otherwise unrelated liver viruses have one important thing in common: a trick for avoiding destruction by the immune system. Both dodge immune attacks by attacking the same protein — an essential link in a chain of molecular signals that triggers antiviral responses.
Doctors need to take concerted action to ensure that people who are at risk of heart disease receive the influenza vaccine every autumn, according to the authors of a new report published in the European Heart Journal.
The GlaxoSmithKline cervical cancer candidate vaccine, CERVARIX(R), demonstrated 100 percent efficacy in preventing precancerous lesions due to cancer-causing human papillomavirus types 16 and 18 for up to 5.5 years in an extended follow-up trial, according to data presented at the American Association for Cancer Research.
The American Australian Association (AAA) is proud to announce that Professor Ian Frazer, named Australian of the Year 2006 for his pivotal work on the human papilloma virus, will be the keynote speaker at Boston Biorelationships on Friday May 4, 2007.
The U.S. Food and Drug Administration (FDA) announced the first approval in the United States of a vaccine for humans against the H5N1 influenza virus, commonly known as avian or bird flu.
A new study in PLoS Medicine has shown that children who have rotavirus, a very common cause of diarrhea in children, and who have antigens (protein fragments from the surface of the virus) in their blood, also have infectious virus in their blood.
Interim Results Presented at EASL from PROVE 1 Clinical Trial of Investigational Drug Telaprevir in Patients with Genotype 1 Hepatitis C. PROVE 1 data support potential to shorten treatment duration in treatment-na?ve, genotype 1 HCV patients.
Researchers at Columbia University’s Mailman School of Public Health have discovered a means for early detection of liver cancer.